Multimeric IgM Antibodies Targeting DR5 are Potent and Rapid Inducers of Tumor Cell Apoptosis In Vitro and In Vivo

PEGS Europe, Barcelona, Spain – November 4, 2021

Angus M. Sinclair, PhD, Vice President, Immuno-oncology Research
IGM Biosciences, Inc., 325 E Middlefield Road, Mountain View, CA 94043

Sinclair-et-al-PEGS-EU-2021

Posted in publications.